H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas

Autor: Pathania, Manav, De Jay, Nicolas, Maestro, Nicola, Harutyunyan, Ashot S., Nitarska, Justyna, Pahlavan, Pirasteh, Henderson, Stephen, Mikael, Leonie G., Richard-Londt, Angela, Zhang, Ying, Costa, Joana R., Hébert, Steven, Khazaei, Sima, Ibrahim, Nisreen Samir, Herrero, Javier, Riccio, Antonella, Albrecht, Steffen, Ketteler, Robin, Brandner, Sebastian, Kleinman, Claudia L., Jabado, Nada, Salomoni, Paolo

Publikováno v: In Cancer Cell 13 November 2017 32(5):684-700

sj-docx-1-tam-10.1177_17588359221113693 – Supplemental material for Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience

Autor: Del Baldo, Giada, Carai, Andrea, Abbas, Rachid, Cacchione, Antonella, Vinci, Mara, Di Ruscio, Valentina, Colafati, Giovanna Stefania, Rossi, Sabrina, Diomedi Camassei, Francesca, Maestro, Nicola, Temelso, Sara, Pericoli, Giulia, De Billy, Emmanuel, Giovannoni, Isabella, Carboni, Alessia, Rinelli, Martina, Agolini, Emanuele, Mackay, Alan, Jones, Chris, Chiesa, Silvia, Balducci, Mario, Locatelli, Franco, Mastronuzzi, Angela

Supplemental material, sj-docx-1-tam-10.1177_17588359221113693 for Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience by Giada Del Baldo, Andrea Carai, Rachid Abbas, Antonella Cacchione, Mara Vinci, Valentina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70927cca87d98ecd08300efa5c363347

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Autor: de Billy E; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pellegrino M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Orlando D; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pericoli G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Ferretti R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Businaro P; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Ajmone-Cat MA; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità-Rome, Rome, Italy., Rossi S; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Petrilli LL; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Maestro N; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Diomedi-Camassei F; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Pezzullo M; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., De Stefanis C; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Bencivenga P; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Palma A; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Rota R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Del Bufalo F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Massimi L; Department of Pediatric Neurosurgery, Catholic University Medical School, Rome, Italy., Weber G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Jones C; Division of Molecular Pathology, Institute of Cancer Research, Sutton, UK., Carai A; Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Caruso S; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., De Angelis B; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Caruana I; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Quintarelli C; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Mastronuzzi A; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Locatelli F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Pediatrics, Sapienza University of Rome, Rome, Italy., Vinci M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.

Publikováno v: Neuro-oncology [Neuro Oncol] 2022 Jul 01; Vol. 24 (7), pp. 1150-1163.